What is BioSig Technologies, Inc.'s marketable securities?

BioSig Technologies, Inc. (STEX) reported marketable securities of $23.77M in Q1 2026.

BioSig Technologies, Inc. STEX Marketable Securities

Marketable Securities at other companies

General DynamicsGD

$207M-1.0%

KLA CorporationKLAC

$3.17B+46.1%

Dime Community Bancshares DCOM

$63.66M-5.0%

DexComDXCM

$1.3B—

CitigroupC

$6.29B+9.7%

MeridianMRBK

$7.7M-8.0%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecurities.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s marketable securities?: BioSig Technologies, Inc. (STEX) reported marketable securities of $23.77M in Q1 2026.